Luigi Antonio Morrone Selected Research

Aromatherapy

4/2020	Role of 5-HT1A Receptor in the Anxiolytic-Relaxant Effects of Bergamot Essential Oil in Rodent.
9/2018	Antinociceptive effect of inhalation of the essential oil of bergamot in mice.
4/2017	Bergamot Essential Oil Attenuates Anxiety-Like Behaviour in Rats.
1/2017	Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms.
9/2010	Neuropharmacology of the essential oil of bergamot.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luigi Antonio Morrone Research Topics

Disease

9	Pain (Aches) 04/2022 - 01/2011
8	Glaucoma 01/2020 - 01/2008
7	Ischemia 01/2017 - 07/2007
5	Dementia (Dementias) 03/2021 - 01/2017
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2008
3	Mood Disorders (Mood Disorder) 01/2019 - 09/2010
2	Migraine Disorders (Migraine) 07/2020 - 01/2019
2	Neoplasms (Cancer) 05/2020 - 01/2015
2	Neuralgia (Stump Neuralgia) 01/2020 - 09/2018
2	Reperfusion Injury 01/2018 - 01/2017
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 04/2022
1	Muscle Spasticity (Spastic) 04/2022
1	Pruritus (Itching) 03/2021
1	Phototoxic Dermatitis (Phototoxicity) 03/2021
1	Chronic Pain 02/2021
1	Nociceptive Pain 01/2021
1	Drug-Related Side Effects and Adverse Reactions 07/2020
1	Hyperalgesia 01/2020
1	Mental Disorders (Mental Disorder) 01/2019
1	Anxiety Disorders (Anxiety Disorder) 01/2019
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2018
1	Retinal Artery Occlusion 01/2018
1	Ganglion Cysts (Ganglion) 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Dyskinesias (Dyskinesia) 12/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2011
1	Neuroblastoma 11/2011
1	Cancer Pain 09/2010
1	Epilepsy (Aura) 01/2009
1	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 01/2008
1	Blindness (Hysterical Blindness) 01/2008
1	Nervous System Diseases (Neurological Disorders) 01/2008

Drug/Important Bio-Agent (IBA)

9	Volatile Oils (Essential Oils)IBA 03/2021 - 09/2010
8	Retinaldehyde (Retinal)IBA 01/2018 - 07/2007
5	Analgesics (Analgesic Drugs)IBA 03/2021 - 10/2017
4	Pharmaceutical PreparationsIBA 07/2020 - 12/2014
3	Glutamic Acid (Glutamate)FDA Link 01/2013 - 01/2008
2	Antipsychotic Agents (Antipsychotics)IBA 03/2021 - 02/2021
2	Gabapentin (Neurontin)FDA LinkGeneric 02/2021 - 01/2020
2	Antidepressive Agents (Antidepressants)IBA 02/2021 - 01/2019
2	Tryptamines (Triptans)IBA 07/2020 - 01/2019
2	AntioxidantsIBA 01/2020 - 01/2018
2	linaloolIBA 01/2011 - 01/2009
2	CannabinoidsIBA 01/2008 - 07/2007
2	EndocannabinoidsIBA 01/2008 - 07/2007
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2022
1	5-MethoxypsoralenIBA 03/2021
1	Opioid Analgesics (Opioids)IBA 02/2021
1	Pregabalin (Lyrica)FDA Link 02/2021
1	Serotonin (5 Hydroxytryptamine)IBA 07/2020
1	Krebs-Ringer solutionIBA 05/2020
1	Atropine FDA LinkGeneric 05/2020
1	Tetrodotoxin (Tetradotoxin)IBA 05/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	mesoglycanIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	fremanezumabIBA 01/2019
1	BenzodiazepinesIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	eptinezumabIBA 01/2019
1	galcanezumabIBA 01/2019
1	erenumabIBA 01/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2019
1	Calcitonin Gene-Related PeptideIBA 01/2019
1	gamma-Aminobutyric Acid (GABA)IBA 01/2019
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	methanesulfonate salt 2-hydroxy-4,4'-diamidinostilbeneIBA 01/2017
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2017
1	Dopamine (Intropin)FDA LinkGeneric 12/2014
1	IsoenzymesIBA 12/2014
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 12/2014
1	Amantadine (Aman)FDA LinkGeneric 12/2014
1	Levodopa (L Dopa)FDA LinkGeneric 12/2014
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2013
1	CaspasesIBA 11/2011
1	Morphine (MS Contin)FDA LinkGeneric 01/2011
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2009
1	coenzyme Q10 (CoQ10)IBA 01/2008
1	Free Radical ScavengersIBA 01/2008
1	Free RadicalsIBA 01/2008
1	Mitochondrial Permeability Transition PoreIBA 01/2008
1	anandamide (arachidonylethanolamide)IBA 07/2007

Therapy/Procedure

5	Aromatherapy 04/2020 - 09/2010
5	Therapeutics 01/2019 - 01/2008
1	Off-Label Use 03/2021
1	Baths 05/2020
1	Caloric Restriction 01/2020